Anti-adalimumab antibodies in psoriasis: lack of clinical utility and laboratory evidence


OBJECTIVE Adalimumab has proven effective in psoriasis; however, secondary failure may result from the drug's immunogenicity. Prevalence data on the immunogenicity of biologicals, and of adalimumab in particular, are highly variable. We investigated the prevalence of anti-adalimumab antibodies and the association with clinical indexes and tumour necrosis… (More)
DOI: 10.1136/bmjopen-2016-011941


1 Figure or Table